Giuseppe Ciaramella, President and CSO at Beam Therapeutics Inc. (BEAM), sold 311,854 shares at $32.06 ($10.0M) on 2023-07-21, disclosed to the SEC on 2023-07-25.
Scheduled sale ($10.0M) by President and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.06 | 155,324 | $5.0M | 49.8% |
| 2 | $32.06 | 155,324 | $5.0M | 49.8% |
| 3 | $32.01 | 1,206 | $39K | 0.4% |
| Total | $32.06 avg | 311,854 | $10.0M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |